Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fishbane

Showing results (261-270 of 357) with videos related to

Pageof 36
Sort By:
Kidney360|July 22, 2024
Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin StudiesSteven N Fishbane, Geoff A Block, Pieter Evenepoel, et al.
American Journal of Hematology|March 26, 2018
Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemiaPablo E Pergola, Steven Fishbane, Robin D LeWinter, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Considerations and challenges in defining optimal iron utilization in hemodialysisDavid M Charytan, Amy Barton Pai, Christopher T Chan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2010
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysisSteven Fishbane, James Delmez, Wadi N Suki, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|August 8, 2021
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis SettingSteven Fishbane, David M Charytan, Glenn M Chertow, et al.
American Journal of Nephrology|January 22, 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2Steven Fishbane, Deborah J Clegg, Edgar V Lerma, et al.
Kidney Medicine|August 1, 2020
Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label StudiesJay B Wish, Marcelo G Rocha, Nancy E Martin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2016
Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney FoundationJay B Wish, Chaim Charytan, Glenn M Chertow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2026
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKDDiana I Jalal, Nisha Bansal, Monique E Cho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2018
Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analysesGeoffrey A Block, Pablo E Pergola, Steven Fishbane, et al.
Pageof 36

Showing results (261-270 of 357) with videos related to

Sort By:
Pageof 36
Kidney360|July 22, 2024
Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin StudiesSteven N Fishbane, Geoff A Block, Pieter Evenepoel, et al.
American Journal of Hematology|March 26, 2018
Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemiaPablo E Pergola, Steven Fishbane, Robin D LeWinter, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Considerations and challenges in defining optimal iron utilization in hemodialysisDavid M Charytan, Amy Barton Pai, Christopher T Chan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2010
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysisSteven Fishbane, James Delmez, Wadi N Suki, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|August 8, 2021
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis SettingSteven Fishbane, David M Charytan, Glenn M Chertow, et al.
American Journal of Nephrology|January 22, 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2Steven Fishbane, Deborah J Clegg, Edgar V Lerma, et al.
Kidney Medicine|August 1, 2020
Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label StudiesJay B Wish, Marcelo G Rocha, Nancy E Martin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2016
Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney FoundationJay B Wish, Chaim Charytan, Glenn M Chertow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2026
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKDDiana I Jalal, Nisha Bansal, Monique E Cho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2018
Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analysesGeoffrey A Block, Pablo E Pergola, Steven Fishbane, et al.
Pageof 36